Medscape2h
Inflammation Now the Key Target for Seborrheic Dermatitis
Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...
Health on MSN3d
FDA: Popular Eye Drops Recalled Over Fungal Contamination, Risk of Eye Infection
A batch of Systane Lubricant Eye Drops Ultra PF has been recalled after a customer complained of "foreign matter" in the ...
Too Old to Operate2d
Advances in Fungal Treatments for HND
The following is a summary of “Fungal Head and Neck Dermatitis: Current Understanding and Management,” published in the July ...
Pharmaceutical Technology6d
Fosravuconazole by Eisai for Fungal Infections: Likelihood of Approval
Fosravuconazole is under clinical development by Eisai and currently in Phase III for Fungal Infections. According to GlobalData, Phase III drugs for Fungal Infections have a 53% phase transition ...